01681.HK
Consun Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 13.31
+1.06%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenHKD 13.24
From 52W high−31.25%
Volume1.26M
Market capHKD 11.29B
P/E (TTM)8.2x
P/S (TTM)2.7x
Div yield5.86%
Key dataSep 18, 2026
Open
HKD 13.24
From 52W high
−31.25%
Volume
1.26M
Market cap
HKD 11.29B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.6x
P/E (TTM)
8.2x
RSI (14)
47.4
MomentumView details →
1D Return
+1.06%
YTD Return
−14.90%
Similar companies
Latest newsMore news →
Consun Pharmaceutical Group repurchased 50,000 of its own shares on September 17 at prices between HK$13.09 and HK$13.15 per share, for about HK$655,300.2d agoChina Shineway Pharmaceutical Group Limited announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 1.785 billion, up 13.8% year-on-year, and profit attributable to shareholders of RMB 595 million, up 19.5% year-on-year.25d ago